ECOR electroCore, Inc.

9.720USD-2.02%Mkt Cap: 87.63M $P/E: —

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.…

Key Statistics

Company
Market Cap87.63M USD
Enterprise Value88.96M USD
Revenue (TTM)36.97M USD
Gross Profit27.79M USD
Net Income (TTM)-13.97M USD
Revenue/Share4.14 USD
Last Price9.720 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees83
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-18.04
PEG—
EV/EBITDA-6.51
EV/Revenue2.41
P/S2.42
P/B-32.00
EPS (TTM)-1.62
EPS (Forward)-0.55
52W Range
4.41064% of range12.70
52W High12.70 USD
52W Low4.410 USD
Profitability
Gross Margin86.75%
Oper. Margin-29.33%
EBITDA Margin-36.96%
Profit Margin-43.60%
ROE817.20%
ROA-74.82%
Growth
Revenue Growth28.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.19M USD
CapEx (TTM)66.00K USD
FCF Margin-12.67%
FCF Yield-5.34%
Net Debt-481.00K USD
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity-5.50
Current Ratio1.21
Quick Ratio0.94
Book Value/Sh-0.31 USD
Cash/Share1.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateFeb 15, 2023
Analyst Consensus
Rating—
Target (Mean)19.17 USD
Upside (mean)+97.2%
Target Range12.00 USD – 26.00 USD
12.00+97.2% to mean26.00
# Analysts5
Ownership
Shares Out.9.02M
Float5.98M
Insiders34.19%
Institutions11.64%
Short Interest
Short Ratio4.2d
Short % Float3.73%
Short % Out.3.58%
Shares Short322.37K
Short (prev mo.)322.42K
Technical
SMA 509.417 (+3.2%)
SMA 2007.433 (+30.8%)
Beta1.05
S&P 52W Chg16.45%
Avg Vol (30d)76.42K
Avg Vol (10d)83.91K
Technical Indicators
RSI (14)45.2
MACD0.2364
MACD Signal0.4812
MACD Hist.-0.2449
BB Upper12.43 USD
BB Middle10.47 USD
BB Lower8.524 USD
BB Width37.25%
ATR (14)0.7271 USD
Vol Ratio (20d)0.67x